Temsirolimus treatment to improve below-knee artery procedures
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies whether delivering a medicine called temsirolimus directly into the artery during a below-knee revascularization procedure can improve blood flow and outcomes. It may help people with severe leg artery disease who have symptoms like pain while walking or threatened limb tissue loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and understand the study, and you’re able to attend follow-up visits.
- You are 18 or older, and if you can become pregnant, you will use highly effective birth control for 90 days after treatment.
- You have severe leg symptoms from poor circulation: either severe claudication (Rutherford 3) or chronic limb-threatening ischemia (Rutherford 4–5).
- Your blocked vessel is in the below-knee area (tibial/peroneal or below-knee popliteal), and the blockage fits specific size and location measurements.
- Your procedure must successfully open the artery with good blood flow to the foot, and no major complications after treatment.
- You have no major reasons to be excluded, such as recent major blood vessel procedures, life expectancy under 1 year, major infection, certain blood test problems, or inability to receive temsirolimus or contrast dye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special stent-like device placed in blocked arteries below the knee to improve blood flow in people with critical limb ischemia. If you meet the artery and health requirements, the goal is to reduce artery re-blocking and help prevent worsening leg problems over 12 months.
This trial compares two balloon treatments used during a procedure to open blocked or narrowed arteries in the thigh and behind the knee. It tests whether the sirolimus-coated balloon works better at keeping the artery open than a standard balloon.
This trial tests a drug-coated balloon to open narrowed or blocked arteries in the lower leg (below the knee) and help them stay open. It’s meant for people with significant symptoms, to reduce re-narrowing after treatment.
This trial tests an experimental drug for people with critical limb ischemia, a serious condition where not enough blood reaches the legs. It aims to see if the drug can help with pain or healing of leg ulcers without the need for surgery.
This trial studies a device-based treatment approach for people with blocked (narrowed or fully blocked) arteries in the thigh or behind the knee that reduce blood flow to the leg. It may help improve blood flow and walking ability, but you must meet specific artery and imaging requirements.
This trial tests a new stent to improve blood flow in blocked leg arteries causing severe pain or tissue loss. It may help if you have a long blockage in the upper leg but not below the knee.
Hear when a new Peripheral Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.